Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Henry Niman who wrote (16216)	3/2/1998 1:30:00 PM
From: Andrew C.R. Biddle	Read Replies (1) \| Respond to of 32384

Henry- The Lehman (thanks for posting) report mentioned Corixa CRXA as a company involved with vaccines. I believe Smithkline has licensed some of their work. Are you familiar with them? Regards, Andrew

To: Henry Niman who wrote (16216)	3/2/1998 1:37:00 PM
From: Machaon	Read Replies (1) \| Respond to of 32384

ABC, NBC, CBS... One entire week of biotech hype. Perhaps this is going to be the catalyst for a biotech rally?! Looks like it's going to be a good time to get the VCR's cranking. I've got 4 different VCR's hooked up in line, so I can tape multiple programs at the same time. The Cancer market is a huge one and, in my mind, there is room for multiple drugs and multiple approaches, just like there are currently multiple approaches for heart trouble, asthma, etc. One has to consider the possibility of other competing and effective treatments, under development, for Cancer, and their impact on Ligand's potential results. Regards, Bob